Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune.

First, M R

Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune. [electronic resource] - Transplantation proceedings - 324-5 p. digital

Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0041-1345

10.1016/s0041-1345(98)01646-7 doi


Administration, Oral
Chemistry, Pharmaceutical
Cyclosporine--administration & dosage
Follow-Up Studies
Humans
Immunosuppressive Agents--administration & dosage
Kidney Transplantation--immunology
Metabolic Clearance Rate
Time Factors